{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:12:38Z","timestamp":1793506358841,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","award":["YTP-SYSUCC-0024"],"award-info":[{"award-number":["YTP-SYSUCC-0024"]}],"id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M653217"],"award-info":[{"award-number":["2019M653217"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472041"],"award-info":[{"award-number":["82472041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52271196"],"award-info":[{"award-number":["52271196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071978"],"award-info":[{"award-number":["82071978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515220058"],"award-info":[{"award-number":["2024A1515220058"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-Sen University","doi-asserted-by":"publisher","award":["31610026"],"award-info":[{"award-number":["31610026"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF1200700"],"award-info":[{"award-number":["2021YFF1200700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A04J2128"],"award-info":[{"award-number":["2023A04J2128"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jconrel.2025.113644","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:39:33Z","timestamp":1742301573000},"page":"113644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Inhalable pH-responsive charge-reversal polymer-small interfering RNA polyplexes for directed gene therapy of anaplastic lymphoma kinase fusion-positive lung cancer"],"prefix":"10.1016","volume":"381","author":[{"given":"Jiadong","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113644_bb0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2025.113644_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-small cell lung cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jconrel.2025.113644_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phrs.2012.11.007","article-title":"Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition","volume":"68","author":"Roskoski","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.113644_bb0025","first-page":"330","article-title":"ALK-positive lung cancer: a moving target","volume":"4","author":"Schneider","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2025.113644_bb0030","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-08-2762","article-title":"Inhibition of ALK signaling for cancer therapy","volume":"15","author":"Moss\u00e9","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113644_bb0035","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114296","article-title":"A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC","volume":"14","author":"Lu","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2025.113644_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.713530","article-title":"The resistance mechanisms and treatment strategies for ALK-rearranged non-small cell lung cancer","volume":"11","author":"Pan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.semcdb.2016.09.016","article-title":"Drug resistance in ALK-positive non-small cell lungcancer patients","volume":"64","author":"Qian","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/mco2.42","article-title":"Two novel strategies to overcome the resistance to ALK tyrosine kinase inhibitor drugs: macrocyclic inhibitors and proteolysis-targeting chimeras","volume":"2","author":"Song","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2025.113644_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-019-1052-9","article-title":"The emerging role of the piRNA\/piwi complex in cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.113644_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/nat.2018.0762","article-title":"RNA interference-based cancer drugs: the roadblocks, and the \u201cdelivery\u201d of the promise","volume":"29","author":"Das","year":"2019","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2025.113644_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113644_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113644_bb0080","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113644_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.ajkd.2022.05.012","article-title":"Lumasiran for advanced primary hyperoxaluria type 1: phase 3 ILLUMINATE-C trial","volume":"81","author":"Michael","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2025.113644_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2213-8587(22)00353-9","article-title":"Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial","volume":"11","author":"Ray","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cpt.1974","article-title":"Single-dose pharmacokinetics and pharmacodynamics of transthyretin targeting N-acetylgalactosamine-small interfering ribonucleic acid conjugate, Vutrisiran, in healthy subjects","volume":"109","author":"Habtemariam","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2025.113644_bb0100","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.2023.21835","article-title":"Lepodisiran, an extended-duration short interfering RNA targeting lipoprotein(a): a randomized dose-ascending clinical trial","volume":"330","author":"Nissen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2025.113644_bb0105","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/acs.nanolett.8b05188","article-title":"Mitochondrial surface engineering for multidrug resistance reversal","volume":"19","author":"Chen","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.113644_bb0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12951-022-01689-y","article-title":"Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41698-022-00254-y","article-title":"STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis","volume":"6","author":"Yanagimura","year":"2022","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0120","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-11-3260","article-title":"Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants","volume":"18","author":"Heuckmann","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113644_bb0125","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2015.65.8732","article-title":"Differential Crizotinib response duration among ALK fusion variants in ALK-positive non-small-cell lung cancer","volume":"34","author":"Yoshida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0130","article-title":"Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113644_bb0135","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Recent progress in nucleic acid pulmonary delivery toward overcoming physiological barriers and improving transfection efficiency","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113644_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-020-00345-x","article-title":"Progress in the mechanism and targeted drug therapy for COPD","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113644_bb0145","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","article-title":"Albuterol-budesonide fixed-dose combination rescue inhaler for asthma","volume":"386","author":"Papi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113644_bb0150","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.113644_bb0155","first-page":"4953","article-title":"miR-21-5p ameliorates hyperoxic acute lung injury and decreases apoptosis of AEC II cells via PTEN\/AKT signaling in rats","volume":"20","author":"Qin","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2025.113644_bb0160","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/nar\/gky1239","article-title":"Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo","volume":"47","author":"Biscans","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2025.113644_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121404","article-title":"Facile one-step synthesis of NIR-responsive siRNA-inorganic hybrid nanoplatform for imaging-guided photothermal and gene synergistic therapy","volume":"282","author":"Jia","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113644_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122098","article-title":"Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing","volume":"297","author":"Patel","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113644_bb0175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jconrel.2022.10.052","article-title":"Nebulization of extracellular vesicles: a promising small RNA delivery approach for lung diseases","volume":"352","author":"Han","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113644_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201516","article-title":"Targeted drug\/gene\/photodynamic therapy via a stimuli-responsive dendritic-polymer-based nanococktail for treatment of EGFR-TKI-resistant non-small-cell lung cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113644_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2019.12.032","article-title":"Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo","volume":"319","author":"Zhupanyn","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113644_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.msec.2015.01.011","article-title":"Click modification of helical amylose by poly(l-lysine) dendrons for non-viral gene delivery","volume":"49","author":"Pang","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2025.113644_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127467","article-title":"A co-carrier for plasmid DNA and curcumin delivery to treat pancreatic cancer via dendritic poly(l-lysine) modified amylose","volume":"253","author":"Pang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119097","article-title":"Co-delivery of doxorubicin and siRNA by all-trans retinoic acid conjugated chitosan-based nanocarriers for multiple synergistic antitumor efficacy","volume":"283","author":"Liu","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.113644_bb0205","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1016\/j.biomaterials.2012.07.036","article-title":"Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation","volume":"33","author":"Tzeng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113644_bb0210","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113644_bb0215","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113644_bb0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/cr00066a003","article-title":"Heterogeneous catalytic transfer hydrogenation and its relation to other methods for reduction of organic compounds","volume":"85","author":"Johnstone","year":"1985","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113644_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1024178830961","article-title":"Heterogeneous catalytic transfer hydrogenation in peptide synthesis","volume":"9","author":"Gowda","year":"2002","journal-title":"Lett. Pept. Sci."},{"key":"10.1016\/j.jconrel.2025.113644_bb0230","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-15-0016","article-title":"Induction of PD-L1 expression by the EML4-ALK oncoprotein and downstream signaling pathways in non-small cell lung cancer","volume":"21","author":"Ota","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113644_bb0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2025.113644_bb0240","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1021\/ct200162x","article-title":"Nucleic acids force field based on reference quantum chemical calculations of glycosidic torsion profiles","volume":"7","author":"Zgarbov\u00e1","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2025.113644_bb0245","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2025.113644_bb0250","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2025.113644_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.jconrel.2025.113644_bb0260","first-page":"2019","author":"Case","year":"2019","journal-title":"Amber"},{"issue":"33\u201338","key":"10.1016\/j.jconrel.2025.113644_bb0265","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.jconrel.2025.113644_bb0270","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2025.113644_bb0275","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2025.113644_bb0280","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular-dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2025.113644_bb0285","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2025.113644_bb0290","article-title":"A cyclodiaryliodonium NOX inhibitor for the treatment of pancreatic cancer via enzyme-activatable targeted delivery by sulfated glycosaminoglycan derivatives","volume":"12","author":"Pang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113644_bb0295","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1021\/acsomega.1c00351","article-title":"Upper critical solution temperature behavior of pH-responsive amphoteric statistical copolymers in aqueous solutions","volume":"6","author":"Sharker","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2025.113644_bb0300","doi-asserted-by":"crossref","first-page":"16743","DOI":"10.1021\/acsnano.3c03279","article-title":"Comprehensively optimizing Fenton reaction factors for antitumor chemodynamic therapy by charge-reversal theranostics","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113644_bb0305","article-title":"A lysosome-activated tetrahedral nanobox for encapsulated siRNA delivery","volume":"34","author":"Gao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113644_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114335","article-title":"The pulmonary biopharmaceutics and anti-inflammatory effects after intratracheal and intravenous administration of re-Du-Ning injection","volume":"160","author":"Jia-Xing","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.113644_bb0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2022.08.003","article-title":"Pulmonary delivery of size-transformable nanoparticles improves tumor accumulation and penetration for chemo-sonodynamic combination therapy","volume":"350","author":"Ma","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113644_bb0320","first-page":"L565","article-title":"Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice","volume":"280","author":"Glaab","year":"2001","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2025.113644_bb0325","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1021\/acsnano.2c06629","article-title":"Near-infrared phototheranostic iron pyrite nanocrystals simultaneously induce dual cell death pathways via enhanced Fenton reactions in triple-negative breast cancer","volume":"17","author":"Zhao","year":"2023","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:54:36Z","timestamp":1769219676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925002640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":65,"alternative-id":["S0168365925002640"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113644","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable pH-responsive charge-reversal polymer-small interfering RNA polyplexes for directed gene therapy of anaplastic lymphoma kinase fusion-positive lung cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113644"}}